Cargando…
Donor CYP3A5 Expression Decreases Renal Transplantation Outcomes in White Renal Transplant Recipients
BACKGROUND: After renal transplantation, immunosuppressants should be administered to prevent organ rejection and prolong graft survival. One of them is tacrolimus, which is metabolized by the CYP3A enzyme family. The variability of the CYP3A5 gene in renal transplant recipients has been previously...
Autores principales: | Warzyszyńska, Karola, Zawistowski, Michał, Karpeta, Edyta, Jałbrzykowska, Agnieszka, Kosieradzki, Maciej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339223/ https://www.ncbi.nlm.nih.gov/pubmed/35879888 http://dx.doi.org/10.12659/AOT.936276 |
Ejemplares similares
-
Single-center experience with perioperative antibiotic prophylaxis and surgical site infections in kidney transplant recipients
por: Ostaszewska, Agata, et al.
Publicado: (2022) -
Development and Validation of the New Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of Unbound Tacrolimus in the Plasma Ultrafiltrate of Transplant Recipients
por: Bodnar-Broniarczyk, Magdalena, et al.
Publicado: (2022) -
Donor-Recipient Size Mismatch in Paediatric Renal Transplantation
por: Donati-Bourne, J., et al.
Publicado: (2014) -
Donor-Derived Urothelial Carcinoma in Renal Transplant Recipients
por: Qian, Zhiyu, et al.
Publicado: (2022) -
Accelerated hepatocellular carcinoma recurrence rate after postoperative direct-acting antivirals treatment – preliminary report
por: Warzyszyńska, Karola, et al.
Publicado: (2017)